Wolfe Research analyst Mike Polark initiates coverage on DexCom (NASDAQ:DXCM) with a Outperform rating and announces Price Target of $121.
Huntington Bancshares Gets Bullish Upgrade, Analyst Forecasts Accelerated Growth Despite Rate Worries
Huntington Bancshares upgraded to Buy with $16 price target, predicted revenue growth and EPS increase. Positive outlook for FY24 and FY25.